A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol.
Saved in:
| Title: | A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol. |
|---|---|
| Authors: | Gribaleva E; Unit for Paediatric and Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London, London, UK., Krogh NS; ZiteLab Aps, Copenhagen, Denmark., Prieto-Merino D; Unit for Paediatric and Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London, London, UK.; Faculty of Medicine, University of Alcalá, Alcalá de Henares, Spain., Coker B; Research and Development Department, Guy's and St Thomas' NHS Foundation Trust, London, UK., Jackson A; Pfizer Healthcare Ireland, Dublin, Ireland., Akkoc A; ZiteLab Aps, Copenhagen, Denmark., Birkner T; Center for Evidence-Based Healthcare, University Hospital Carle Gustav Carus Dresden and Medical Faculty, TU Dresden, Dresden, Sachsen, Germany., Bruninx E; Pfizer NV/SA, Brussels, Belgium., Hennessy C; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Chan K; St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Trust, London, UK.; School of Public Health, Brown University, Providence, RI, USA., Cutlar L; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Farrell B; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Fletcher G; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Gerbens L; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Frostrup AG; Pfizer ApS, Ballerup, Denmark., Henrohn D; Pfizer AB, Stockholm, Sweden.; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Hyseni A; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Irvine AD; Department of Clinical Medicine, Trinity College, Dublin, Ireland., Malek R; Department of Life Sciences and Medicine, King's College London, London, UK., McCarthy C; Pfizer Healthcare Ireland, Dublin, Ireland., Vittrup I; Department of Dermatology, Copenhagen University Hospital, Copenhagen, Denmark., Ouwerkerk W; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Randall R; Pfizer Ltd, Tadworth, UK., Spuls PI; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Thomsen SF; Department of Dermatology, Copenhagen University Hospital, Copenhagen, Denmark., Wall D; Hair Restoration Blackrock, Dublin, Ireland.; Charles Institute of Dermatology, School of Medicine, University College Dublin, Dublin, Ireland., Weidinger S; Department of Dermatology and Allergy, University Hospital Schleswig Holstein, Kiel, Schleswig-Holstein, Germany., Werfel T; Department of Dermatology, Hannover Medical School, Hannover, Germany., Schmitt J; Center for Evidence-Based Healthcare, University Hospital Carle Gustav Carus Dresden and Medical Faculty, TU Dresden, Dresden, Sachsen, Germany., Flohr C; Unit for Paediatric and Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London, London, UK. |
| Source: | Skin health and disease [Skin Health Dis] 2025 Apr 22; Vol. 5 (3), pp. 196-202. Date of Electronic Publication: 2025 Apr 22 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9918227353706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2690-442X (Electronic) Linking ISSN: 2690442X NLM ISO Abbreviation: Skin Health Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40584946 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gribaleva+E%22">Gribaleva E</searchLink>; Unit for Paediatric and Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Krogh+NS%22">Krogh NS</searchLink>; ZiteLab Aps, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Prieto-Merino+D%22">Prieto-Merino D</searchLink>; Unit for Paediatric and Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London, London, UK.; Faculty of Medicine, University of Alcalá, Alcalá de Henares, Spain.<br /><searchLink fieldCode="AU" term="%22Coker+B%22">Coker B</searchLink>; Research and Development Department, Guy's and St Thomas' NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Jackson+A%22">Jackson A</searchLink>; Pfizer Healthcare Ireland, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Akkoc+A%22">Akkoc A</searchLink>; ZiteLab Aps, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Birkner+T%22">Birkner T</searchLink>; Center for Evidence-Based Healthcare, University Hospital Carle Gustav Carus Dresden and Medical Faculty, TU Dresden, Dresden, Sachsen, Germany.<br /><searchLink fieldCode="AU" term="%22Bruninx+E%22">Bruninx E</searchLink>; Pfizer NV/SA, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Hennessy+C%22">Hennessy C</searchLink>; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Chan+K%22">Chan K</searchLink>; St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Trust, London, UK.; School of Public Health, Brown University, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Cutlar+L%22">Cutlar L</searchLink>; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Farrell+B%22">Farrell B</searchLink>; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Fletcher+G%22">Fletcher G</searchLink>; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Gerbens+L%22">Gerbens L</searchLink>; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Frostrup+AG%22">Frostrup AG</searchLink>; Pfizer ApS, Ballerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Henrohn+D%22">Henrohn D</searchLink>; Pfizer AB, Stockholm, Sweden.; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Hyseni+A%22">Hyseni A</searchLink>; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Irvine+AD%22">Irvine AD</searchLink>; Department of Clinical Medicine, Trinity College, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Malek+R%22">Malek R</searchLink>; Department of Life Sciences and Medicine, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22McCarthy+C%22">McCarthy C</searchLink>; Pfizer Healthcare Ireland, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Vittrup+I%22">Vittrup I</searchLink>; Department of Dermatology, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Ouwerkerk+W%22">Ouwerkerk W</searchLink>; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Randall+R%22">Randall R</searchLink>; Pfizer Ltd, Tadworth, UK.<br /><searchLink fieldCode="AU" term="%22Spuls+PI%22">Spuls PI</searchLink>; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Thomsen+SF%22">Thomsen SF</searchLink>; Department of Dermatology, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Wall+D%22">Wall D</searchLink>; Hair Restoration Blackrock, Dublin, Ireland.; Charles Institute of Dermatology, School of Medicine, University College Dublin, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Weidinger+S%22">Weidinger S</searchLink>; Department of Dermatology and Allergy, University Hospital Schleswig Holstein, Kiel, Schleswig-Holstein, Germany.<br /><searchLink fieldCode="AU" term="%22Werfel+T%22">Werfel T</searchLink>; Department of Dermatology, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Schmitt+J%22">Schmitt J</searchLink>; Center for Evidence-Based Healthcare, University Hospital Carle Gustav Carus Dresden and Medical Faculty, TU Dresden, Dresden, Sachsen, Germany.<br /><searchLink fieldCode="AU" term="%22Flohr+C%22">Flohr C</searchLink>; Unit for Paediatric and Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London, London, UK. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918227353706676%22">Skin health and disease</searchLink> [Skin Health Dis] 2025 Apr 22; Vol. 5 (3), pp. 196-202. <i>Date of Electronic Publication: </i>2025 Apr 22 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918227353706676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2690-442X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222690442X%22">2690442X </searchLink><i>NLM ISO Abbreviation: </i>Skin Health Dis <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40584946 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/skinhd/vzaf020 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 196 Titles: – TitleFull: A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gribaleva E – PersonEntity: Name: NameFull: Krogh NS – PersonEntity: Name: NameFull: Prieto-Merino D – PersonEntity: Name: NameFull: Coker B – PersonEntity: Name: NameFull: Jackson A – PersonEntity: Name: NameFull: Akkoc A – PersonEntity: Name: NameFull: Birkner T – PersonEntity: Name: NameFull: Bruninx E – PersonEntity: Name: NameFull: Hennessy C – PersonEntity: Name: NameFull: Chan K – PersonEntity: Name: NameFull: Cutlar L – PersonEntity: Name: NameFull: Farrell B – PersonEntity: Name: NameFull: Fletcher G – PersonEntity: Name: NameFull: Gerbens L – PersonEntity: Name: NameFull: Frostrup AG – PersonEntity: Name: NameFull: Henrohn D – PersonEntity: Name: NameFull: Hyseni A – PersonEntity: Name: NameFull: Irvine AD – PersonEntity: Name: NameFull: Malek R – PersonEntity: Name: NameFull: McCarthy C – PersonEntity: Name: NameFull: Vittrup I – PersonEntity: Name: NameFull: Ouwerkerk W – PersonEntity: Name: NameFull: Randall R – PersonEntity: Name: NameFull: Spuls PI – PersonEntity: Name: NameFull: Thomsen SF – PersonEntity: Name: NameFull: Wall D – PersonEntity: Name: NameFull: Weidinger S – PersonEntity: Name: NameFull: Werfel T – PersonEntity: Name: NameFull: Schmitt J – PersonEntity: Name: NameFull: Flohr C IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 04 Text: 2025 Apr 22 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2690-442X Numbering: – Type: volume Value: 5 – Type: issue Value: 3 Titles: – TitleFull: Skin health and disease Type: main |
| ResultId | 1 |
